Syndax Pharmaceuticals Inc (SNDX)
12.01
-0.28
(-2.24%)
USD |
NASDAQ |
Apr 01, 16:00
12.54
+0.53
(+4.41%)
Pre-Market: 08:11
Syndax Pharmaceuticals Max Drawdown (5Y): 60.70% for March 31, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Seres Therapeutics Inc | 98.54% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 98.13% |
| Theriva Biologics Inc | 99.80% |
| Oragenics Inc | 99.77% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -20.80 |
| Beta (5Y) | 1.281 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 51.59% |
| Historical Sharpe Ratio (5Y) | -0.0061 |
| Historical Sortino (5Y) | -0.0111 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.69% |